Nov 22 (Reuters) - Pharmacy services company BioScrip Inc. said it expects to return to profitability in the fourth quarter due to lower bad debt expense and cost reductions. BioScrip, which has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback